Hi, I'm Alex Steele introducing you to the new Stock Movers podcast from Bloomberg, the show that brings you short episodes five minutes or less, covering the stocks making gains and losses in today's trading. Subscribe to Stock Movers on Apple, Spotify, or wherever you get your podcasts.
Now.
Here's a sample of the latest episode from our team at.
Bloomberg Bloomberg Audio Studios, Podcasts, radio News.
The Stock Movers podcast your roundup of companies making moves in the stock market, harnessing the power of Bloomberg data.
Let's look at some stocks on the move today. We are joined by Bloomberg's Critty Gupta on a choppy pre market session for stocks as a whole creaty. That is certainly what we are seeing at the micro level. For Delta, they just reported earnings. What's the stock doing?
Good morning, Good morning, Nathan. We are getting the very first inclination of companies starting to suspend their guidance. This is a really big deal. I'm having a little bit of COVID deja vus here because when you look at some of these numbers, the earnings revisions are key to that chart you've seen massive numbers, massive hits to the tech valuations. A lot of that is only if you do indeed get those earnings revisions from these companies, or like in COVID, you do get a suspension of the
guide of guidance there as well. So Delta d AL is your ticker this morning, actually coming out of the gates hire by about three percent. The market is buying this, which is non traditional, giving that they're withdrawing. They're full of your guidance, calling it given current uncertainty. They're saying that growth has largely stalled. But when you look at their first quarter numbers, they are actually coming in line
with expectation. So the markets buying even just that is quite something to witness because again a very non traditional reaction for really any company that would be suspending it's guidance. Let's talk about some of the other weights in this market. I think the story of the morning, your pharma stocks are taking the biggest beating this morning. I'm just going to run through the laundry list of names this morning. Nathan,
if I can, Aby is top of that list. ABBV is your ticker, down just shy of four percent this morning, one hundred and sixty nine dollars to share, Abbot right on its heels, ABT down about the same margin, trading at one hundred and nineteen dollars a share.
There.
Then you've got Gilliad Sciences as well, Gild down about three percent. I'm seeing if their bonds are selling off in a very big way this morning. Really keep an eye on a on a stock simply because or some of the kind of bonds that are trading. Credit seems to be leading this equity market. So anything that has a massive corporate bond hit is going to be magnified
in the equity market. You're seeing that with Gilliad Sciences, like I said, Gild down about three percent, Bristol Meyers squib as well, Bmy down about three percent, trading at fifty one dollars a share, and some of our favorites there Pfizer PFE down a whopping three percent, trading at twenty one dollars share. Nathan, I could go on and on. The message this morning is if you are a pharmaceutical hit, you are taking a massive hit when it comes to
your stock. And a lot of this is lead actually by some of the pain you've seen right here in Europe as well. The likes of Nova Nordisk, for example, have really been selling off this morning in Europe, alongside Roche and Santa Fe as well. Nova Nordisk, I should mention the ADRs also are available in the United States ENVO for that ticker trading out about sixty dollars and
change down about one point two percent. I'll just mention that about sixty percent of Nova Nordisk's revenue comes from the United States, so this is a really great spot to look at when you're talking about some of the
movement there in the pharmaceutical space. We're also getting some numbers coming out of Walmart, several comments coming from the CEO in the last twenty four hours thing that they're being focused on keeping price as low, prices as low as they possibly can, and really looking at some cost cutting measures. They're reaffirming their first quarter sales guidance. In their full year twenty twenty six guidance remains unchanged, so that's going to be again another major one to watch, Nathan.
For me, Walmart's WMT is the tell those shares hire by two percent this morning.
The Stock Movers podcast Bloomberg Radio check Back with us throughout the day. For the latest roundup of companies making news on Wall Street, and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.